Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review.

Published in: Gut pathogens (2020)

The creation of oncomicrobiotics may allow many patients receiving anti-CTLA-4 and PD-1 immunotherapy to experience prolonged survival and a better quality of life.

Keyphrases

papillary thyroid
microbial community
squamous cell
free survival
childhood cancer
young adults